Nosocomial spontaneous bacterial peritonitis is associated with high mortality – a systematic review and meta-analysis

References

• Tandon P, Garcia-Tsao G. Bacterial infections, sepsis, and multiorgan failure in cirrhosis. Semin Liver Dis. 2008 Feb;28(1):26–42. doi: 10.1055/s-2008-1040319
   PubMed Web of Science ®Google Scholar
• Song JY, Jung SJ, Park CW, et al. Prognostic significance of infection acquisition sites in spontaneous bacterial peritonitis: nosocomial versus community acquired. J Korean Med Sci. 2006;21(4):666–671. doi: 10.3346/jkms.2006.21.4.666
   PubMed Web of Science ®Google Scholar
• Llovet JM, Planas R, Morillas R, et al. Short-term prognosis of cirrhotics with spontaneous bacterial peritonitis: multivariate study. Am J Gastroenterol. 1993 Mar;88(3):388–392.
   PubMed Web of Science ®Google Scholar
• Ariza X, Castellote J, Lora-Tamayo J, et al. Risk factors for resistance to ceftriaxone and its impact on mortality in community, healthcare and nosocomial spontaneous bacterial peritonitis. J Hepatol. 2012 Apr;56(4):825–832. doi: 10.1016/j.jhep.2011.11.010
   PubMed Web of Science ®Google Scholar
• Balaraju G, Patil M, Krishnamurthy AC, et al. Comparative study of community acquired and nosocomial spontaneous bacterial peritonitis and its variants in 150 patients. J Clin Exp Hepatol. 2017;7(3):215–221. doi: 10.1016/j.jceh.2017.03.005
   PubMedGoogle Scholar
• Cheong HS, Kang CI, Lee JA, et al. Clinical significance and outcome of nosocomial acquisition of spontaneous bacterial peritonitis in patients with liver cirrhosis. Clin Infect Dis. 2009 May 1;48(9):1230–1236. doi: 10.1086/597585
   PubMed Web of Science ®Google Scholar
• Guarner C, Solà R, Soriano G, et al. Risk of a first community-acquired spontaneous bacterial peritonitis in cirrhotics with low ascitic fluid protein levels. Gastroenterology. 1999 Aug;117(2):414–419. doi: 10.1053/gast.1999.0029900414
   PubMed Web of Science ®Google Scholar
• Acevedo J. Multiresistant bacterial infections in liver cirrhosis: Clinical impact and new empirical antibiotic treatment policies. World J Hepatol. 2015 May 8;7(7):916–921. doi: 10.4254/wjh.v7.i7.916
   PubMed Web of Science ®Google Scholar
• Ding X, Yu Y, Chen M, et al. Causative agents and outcome of spontaneous bacterial peritonitis in cirrhotic patients: community-acquired versus nosocomial infections. BMC Infect Dis. 2019;19(1):463. doi: 10.1186/s12879-019-4102-4
   PubMedGoogle Scholar
• Fernández J, Acevedo J, Castro M, et al. Prevalence and risk factors of infections by multiresistant bacteria in cirrhosis: a prospective study. Hepatology. 2012 May;55(5):1551–1561. doi: 10.1002/hep.25532
   PubMed Web of Science ®Google Scholar
• Fiore M, Maraolo AE, Gentile I, et al. Nosocomial spontaneous bacterial peritonitis antibiotic treatment in the era of multi-drug resistance pathogens: a systematic review. World J Gastroenterol. Jul 7 2017;23(25):4654–4660. doi: 10.3748/wjg.v23.i25.4654
   PubMed Web of Science ®Google Scholar
• Jain M, Sanglodkar U, Venkataraman J. Risk factors predicting nosocomial, healthcare-associated and community-acquired infection in spontaneous bacterial peritonitis and survival outcome. Clin Exp Hepatol. 2019 May;5(2):133–139. doi: 10.5114/ceh.2019.85073
   PubMed Web of Science ®Google Scholar
• Kimmann M, Tergast TL, Schultalbers M, et al. Sustained impact of nosocomial-acquired spontaneous bacterial peritonitis in different stages of decompensated liver cirrhosis. PLoS One. 2019;14(8):e0220666–e0220666. doi: 10.1371/journal.pone.0220666
   PubMed Web of Science ®Google Scholar
• Lutz P, Nischalke HD, Krämer B, et al. Antibiotic resistance in healthcare-related and nosocomial spontaneous bacterial peritonitis. Eur J Clin Invest. 2017 Jan;47(1):44–52. doi: 10.1111/eci.12701
   PubMed Web of Science ®Google Scholar
• Moher D, Liberati A, Tetzlaff J, et al. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ. 2009;339(jul21 1):b2535. doi: 10.1136/bmj.b2535
   PubMed Web of Science ®Google Scholar
• Chaulk J, Carbonneau M, Qamar H, et al. Third-generation cephalosporin-resistant spontaneous bacterial peritonitis: a single-centre experience and summary of existing studies. Can J Gastroenterol Hepatol. 2014;28(2):83–88. doi: 10.1155/2014/429536
   PubMedGoogle Scholar
• Merli M, Lucidi C, Giannelli V, et al. Cirrhotic patients are at risk for health care-associated bacterial infections. Clin Gastroenterol Hepatol. 2010 Nov;8(11):979–985. doi: 10.1016/j.cgh.2010.06.024
   PubMed Web of Science ®Google Scholar
• Raudenbush SW, Bryk AS. Empirical Bayes Meta-Analysis. J Educ Stat. 1985;10(2):75–98. doi: 10.3102/10769986010002075
   Google Scholar
• Wells GA, Wells G, Shea B, et al. The Newcastle-Ottawa scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. 2014.
   Google Scholar
• Higgins JP, Thompson SG, Spiegelhalter DJ. A re-evaluation of random-effects meta-analysis. J R Stat Soc Ser A Stat Soc. 2009 Jan;172(1):137–159. doi: 10.1111/j.1467-985X.2008.00552.x
   PubMed Web of Science ®Google Scholar
• Riley RD, Ahmed I, Debray TP, et al. Summarising and validating test accuracy results across multiple studies for use in clinical practice. Stat Med. Jun 15 2015;34(13):2081–2103. doi: 10.1002/sim.6471
   PubMed Web of Science ®Google Scholar
• Guyatt GH, Oxman AD, Kunz R, et al. GRADE guidelines: 7. Rating the quality of evidence–inconsistency. J Clin Epidemiol. 2011 Dec;64(12):1294–1302. doi: 10.1016/j.jclinepi.2011.03.017
   PubMed Web of Science ®Google Scholar
• Higgins JP, Thompson SG, Deeks JJ, et al. Measuring inconsistency in meta-analyses. BMJ. Sep 6 2003;327(7414):557–560. doi: 10.1136/bmj.327.7414.557
   PubMedGoogle Scholar
• Kanwal F, White D. “Systematic Reviews and meta-analyses” in clinical gastroenterology and Hepatology. Clin Gastroenterol Hepatol. 2012 Nov;10(11):1184–1186. doi: 10.1016/j.cgh.2012.09.019
   PubMed Web of Science ®Google Scholar
• Petrie A, Bulman JS, Osborn JF. Further statistics in dentistry part 8: systematic reviews and meta-analyses. Br Dent J. Jan 25 2003;194(2):73–78. doi: 10.1038/sj.bdj.4809877
   PubMed Web of Science ®Google Scholar
• Sterne JA, Egger M. Funnel plots for detecting bias in meta-analysis: guidelines on choice of axis. J Clin Epidemiol. 2001 Oct;54(10):1046–1055. doi: 10.1016/s0895-4356(01)00377-8
   PubMed Web of Science ®Google Scholar
• Sterne JA, Sutton AJ, Ioannidis JP, et al. Recommendations for examining and interpreting funnel plot asymmetry in meta-analyses of randomised controlled trials. BMJ. Jul 22 2011;343(jul22 1):d4002. doi: 10.1136/bmj.d4002
   PubMedGoogle Scholar
• Langan D, Higgins JPT, Jackson D, et al. A comparison of heterogeneity variance estimators in simulated random-effects meta-analyses. Res Synth Methods. 2019 Mar;10(1):83–98. doi: 10.1002/jrsm.1316
   PubMed Web of Science ®Google Scholar
• Friedrich K, Nüssle S, Rehlen T, et al. Microbiology and resistance in first episodes of spontaneous bacterial peritonitis: implications for management and prognosis. J Gastroenterol Hepatol. 2016 Jun;31(6):1191–1195. doi: 10.1111/jgh.13266
   PubMed Web of Science ®Google Scholar
• Salerno F, Borzio M, Pedicino C, et al. The impact of infection by multidrug-resistant agents in patients with cirrhosis. A multicenter prospective study. Liver Int. 2017 Jan;37(1):71–79. doi: 10.1111/liv.13195
   PubMed Web of Science ®Google Scholar
• Schultalbers M, Tergast TL, Simon N, et al. Frequency, characteristics and impact of multiple consecutive nosocomial infections in patients with decompensated liver cirrhosis and ascites. United Eur Gastroenterol J. 2020 Jun;8(5):567–576. doi: 10.1177/2050640620913732
   PubMed Web of Science ®Google Scholar
• Kim SU, Chon YE, Lee CK, et al. Spontaneous bacterial peritonitis in patients with hepatitis B virus-related liver cirrhosis: community-acquired versus nosocomial. Yonsei Med J. 2012;53(2):328–336. doi: 10.3349/ymj.2012.53.2.328
   PubMed Web of Science ®Google Scholar
• Li YT, Yu CB, Huang JR, et al. Pathogen profile and drug resistance analysis of spontaneous peritonitis in cirrhotic patients. World J Gastroenterol. Sep 28 2015;21(36):10409–10417. doi: 10.3748/wjg.v21.i36.10409
   PubMed Web of Science ®Google Scholar
• RM EL, Oda MS, Saeed MA, et al. A comparative study on nosocomial and community-acquired spontaneous bacterial peritonitis in patients with liver cirrhosis at a university hospital. Eur J Gastroenterol Hepatol. Jun 1 2022;34(6):655–663. doi: 10.1097/meg.0000000000002328
   PubMed Web of Science ®Google Scholar
• Bert F, Andreu M, Durand F, et al. Nosocomial and community-acquired spontaneous bacterial peritonitis: comparative microbiology and therapeutic implications. Eur J Clin Microbiol Infect Dis. 2003;22(1):10–15. doi: 10.1007/s10096-002-0840-z
   PubMed Web of Science ®Google Scholar
• Chon YE, Kim SU, Lee CK, et al. Community-acquired vs. nosocomial spontaneous bacterial peritonitis in patients with liver cirrhosis. Hepatogastroenterology. 2014 Nov;61(136):2283–2290.
   PubMedGoogle Scholar
• Piroth L, Pechinot A, Di Martino V, et al. Evolving epidemiology and antimicrobial resistance in spontaneous bacterial peritonitis: a two-year observational study. BMC Infect Dis. 2014;14(1):287. doi: 10.1186/1471-2334-14-287
   PubMedGoogle Scholar
• Shi L, Wu D, Wei L, et al. Nosocomial and community-acquired spontaneous bacterial peritonitis in patients with liver cirrhosis in China: comparative microbiology and therapeutic implications. Sci Rep. Apr 6 2017;7(1):46025. doi: 10.1038/srep46025
   PubMedGoogle Scholar
• Pimentel R, Leitão J, Gregório C, et al. Spontaneous bacterial peritonitis in cirrhotic patients: a shift in the microbial pattern? A retrospective analysis. GE Port J Gastroenterol. 2022;29(4):256–266. doi: 10.1159/000518585
   PubMedGoogle Scholar
• Li YT, Huang JR, Peng ML. Current status and prospects of spontaneous peritonitis in patients with cirrhosis. Biomed Res Int. 2020;2020:3743962. doi: 10.1155/2020/3743962
   PubMed Web of Science ®Google Scholar
• Piano S, Fasolato S, Salinas F, et al. The empirical antibiotic treatment of nosocomial spontaneous bacterial peritonitis: results of a randomized, controlled clinical trial. Hepatology. 2016 Apr;63(4):1299–1309. doi: 10.1002/hep.27941
   PubMed Web of Science ®Google Scholar
• Tay PWL, Xiao J, Tan DJH, et al. An epidemiological meta-analysis on the worldwide prevalence, resistance, and outcomes of spontaneous bacterial peritonitis in cirrhosis. Systematic review. Front Med. 2021 Aug 05;8. doi:10.3389/fmed.2021.693652
   Web of Science ®Google Scholar
• Jalan R, Fernandez J, Wiest R, et al. Bacterial infections in cirrhosis: a position statement based on the EASL special conference 2013. J Hepatol. 2014 Jun;60(6):1310–1324. doi: 10.1016/j.jhep.2014.01.024
   PubMed Web of Science ®Google Scholar
• Facciorusso A, Abd El Aziz MA, Singh S, et al. Statin use decreases the incidence of hepatocellular carcinoma: an updated meta-analysis. Cancers (Basel). Apr 3 2020;12(4). doi: 10.3390/cancers12040874
   Web of Science ®Google Scholar